Product logins

Find logins to all Clarivate products below.


chevron_left

Market & Device Trends: Chronic subdural hematoma embolization

Medtech Resource Center Resource Center Thought Leadership
Market & Device Trends: Chronic subdural hematoma embolization

The growing popularity of middle meningeal artery embolization in treating chronic subdural hematoma is being fueled by promising preliminary results from the EMBOLISE, STEM, and MAGIC-MT trials. This surge in physician interest is expected to drive a significant 13.6% global growth in these procedures between 2023 and 2028.

Related insights

The latest news, technologies, and resources from our team.

United States Peripheral Bioresorbable Stent United States Peripheral Bioresorbable Stent
United States Peripheral Bioresorbable Stent
Radioligand innovators ushering in a new era of precision oncology Radioligand innovators ushering in a new era of precision oncology
Radioligand innovators ushering in a new era of precision oncology
North America Dental Implant Market Snapshot North America Dental Implant Market Snapshot
North America Dental Implant Market Snapshot
chevron_left
chevron_right